6-K - DOX - Equibles

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

Form 6-K

REPORT OFFOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934

For the month of November 2024

Commission File Number 1-14840

AMDOCS LIMITED

Hirzel House,Smith Street,

St. Peter Port, Island of Guernsey, GY1 2NG

Amdocs, Inc.

625Maryville Centre Drive, Suite 200, Saint Louis, Missouri 63141

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

FORM 20-F ☒ FORM 40-F ☐

On November 12, 2024 Amdocs Limited (“Amdocs”) issued a press release announcing financial results for the quarter ended September 30, 2024. A copy of the press release and the accompanying presentation are furnished as Exhibits 99.1 and 99.2 to this Report of Foreign Private Issuer on Form 6-K.

The information in this Form 6-K (including Exhibits 99.1 and 99.2) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.

EXHIBIT INDEX

EXHIBIT<br>NO.	DESCRIPTION
99.1	Amdocs Limited Press Release Announcing Q4 Earnings, dated November 12, 2024
99.2	Fiscal Q4 2024 Earnings Presentation

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

AMDOCS LIMITED
By:	/s/ Matthew E. Smith
	Matthew E. Smith
	Secretary and Authorized Signatory

Date: November 12, 2024

EX-99.1

Exhibit 99.1

LOGO

Amdocs Limited Reports Fourth Quarter Fiscal 2024 Results & Full Year Fiscal 2024 Results

Record Fiscal 2024 Revenue of $5.00 Billion, up 2.4% YoY as Reported and 2.7% YoY^^in Constant Currency^(1)^

Successfully Achieved Accelerated ProfitabilityImprovement Targets

Initiates Fiscal 2025 Outlook:

Sharpening Focus on Strategic Priorities while Phasing Out Certain Non-Core, Low Margin BusinessActivities

As a Result of which Expects Fiscal 2025 Revenue Outlook of (10.9)%-(7.7)% YoY as Reported and 1%-4.5% YoY in Pro Forma^(2)^ Constant Currency^(1)^

Targeting Double-Digit Total Shareholder Returns^(3)(4)^, Supported by EnhancedProfitability Improvement

Board Approves 10% Increase of Quarterly CashDividend^(4)^

Full Year Fiscal 2024 Highlights

(All comparisons are against the prior year)

•	Record revenue of $5,005 million, up 2.4% as reported and up 2.7% in constant currency^(^^1)^, including record revenue of $3,326 million in North America, record revenue of $726 million in Europe and record revenue of<br>$953 million in Rest of World
•	Record managed services revenue of $2,905 million, equivalent to approximately 58% of total revenue<br>
---	---
•	GAAP diluted EPS of $4.25, down 5.3%, including a restructuring charge of 98 cents per share, without which GAAP<br>diluted EPS was $5.23
---	---
•	Non-GAAP diluted EPS of $6.44, up 9.0%
---	---
•	Free cash flow of $619 million, comprised of cash flow from operations of $724 million, less<br>$105 million in net capital expenditures and other^(5)^, and including $75 million of restructuring payments not assumed in full year free cash flow guidance of $700 million<br>
---	---
(1)	Revenue on a constant currency basis assumes exchange rates in the current period were unchanged from the prior<br>period
---	---
(2)	For comparison purposes, pro forma adjusts fiscal 2024 revenue by approximately $600 million to reflect<br>the end of certain low margin, non-core business activities; these activities substantially already ceased in the first quarter of fiscal 2025 and are not included in the full year fiscal 2025 revenue outlook<br>
---	---
(3)	Expected total shareholder return assumes midpoint of fiscal year 2025<br>non-GAAP EPS growth outlook, plus dividend yield
---	---
(4)	Subject to shareholder approval at January 2025 annual meeting
---	---
(5)	Please refer to the Selected Financial Metrics tables below (figures may not sum because of rounding)<br>
---	---
•	Repurchased $563 million of ordinary shares during the fiscal year
---	---
•	Twelve-month backlog of $4.06 billion; adjusting comparable periods for the phase out of certain business<br>activities, twelve-month backlog was up 2.5%^(2)^ as compared to last year’s fourth fiscal quarter, and up approximately $30 million^(^^2)^ sequentially
---	---

Fourth Quarter Fiscal 2024 Highlights

(All comparisons are against the prior year)

•	Record revenue of $1,264 million, up 1.7% as reported and up 2.1% in constant currency^(^^1)^; revenue was slightly above the midpoint of the $1,240-$1,280 million guidance range, adjusting for<br>a positive impact from foreign currency movements of approximately $3 million compared to our guidance assumptions
•	GAAP diluted EPS of $0.76, including a restructuring charge of 0.64 cents per share, without which GAAP diluted<br>EPS would have been at the higher end of the guidance range of $1.34-$1.42
---	---
•	Non-GAAP diluted EPS of $1.70, at the midpoint of the guidance range of $1.67-$1.73
---	---
•	GAAP operating income of $113 million, including a restructuring charge of $83 million; GAAP operating<br>margin of 8.9%, down 230 basis points as compared to last year’s fourth fiscal quarter and down 520 basis points sequentially
---	---
•	Non-GAAP operating income of $236 million; non-GAAP operating margin of 18.7%, up 90 basis points as compared to last year’s fourth fiscal quarter and up 10 basis points sequentially, reflecting a continued focus on operational excellence<br>
---	---
•	The Board of Directors (the “Board”) approved a 10% increase in the Company’s quarterly cash<br>dividend payment from $0.479 per share to $0.527 per share, anticipated to be first paid in April 2025, subject to shareholder approval at the January 2025 annual meeting
---	---

JERSEY CITY, NJ – November 12, 2024 – Amdocs Limited (NASDAQ: DOX), a leading provider of software and services to communications and media companies, today reported operating results for the three months ended September 30, 2024.

“Fiscal 2024 was another important year in our journey as we continued to serve many of the world’s largest communication service providers with the innovation they need to accelerate their journey to the cloud, enhance customer experience, monetize next generation networks, and to digitalize and automate their mission critical operations. We delivered strong double-digit growth in cloud, achieved a record year in managed services, and accelerated our profitability, all within the backdrop of a challenging industry demand environment. The year closed with strong sales momentum which included a significant award to deploy our next-gen monetization platform for a major US customer, and new cloud migration deals with Vodafone Italy and NTT Infranet in Japan. Additionally, we have continued to enhance our generative AI platform, amAIz, with new capabilities that leverage NVIDIA AI to deliver immersive customer experiences with real-time interaction and visualization,” said Shuky Sheffer, president and chief executive officer of Amdocs Management Limited.

“Consistent with our full year guidance, we delivered accelerated profitability improvement in fiscal 2024 as we focused on operational excellence and the benefits of automation and artificial intelligence to drive internal efficiency. We continue to invest in our strategic priorities, while at the same time optimizing the portfolio of products, services, and business activities. Thus, in fiscal 2025, we are phasing out several low-margin, non-core business activities that are becoming commoditized and hold little potential for long-term value addition or profitability enhancement. We believe these actions will reinforce our level of business visibility, including a higher share of revenue from long-term managed services engagements. This move is also expected to sharpen our focus on higher-margin strategic priorities like cloud, monetization platforms and Gen AI where we are well placed to lead the communications industry through our commitment to innovation,” said Tamar Rapaport-Dagim, chief financial officer & chief operating officer of Amdocs Management Limited.

Sheffer concluded, “We enter fiscal 2025 as an industry leader with a unique competitive position, strong 12-month backlog visibility, and a high win rate. Moreover, we believe Amdocs is well positioned to monetize a healthy pipeline of market opportunities while navigating a continuously challenging demand environment. Adjusting for the phase out of several low-margin, non-core business activities, we expect pro forma^(2)^ revenue growth of between 1% to 4.5% in constant currency^(1)^ in fiscal 2025, as well as another year of double-digit growth in cloud. We also anticipate significantly higher operating profitability and robust earnings to cash conversion, underpinning the delivery of double-digit expected total shareholder returns^(3)^ for the fifth consecutive year, including our dividend yield.”

Revenue

(All comparisons areagainst the prior year period)

	In millions
	Three months ended					Twelve months ended
	September 30, 2024					September 30, 2024
	Actual			Previous<br>Guidance		Actual			Previous<br>Guidance
Revenue	$	1,264		$	1,240-$1,280	$	5,005			—
Revenue Growth, as reported		1.7	%		—		2.4	%		1.9%-2.7%
Revenue Growth, constant currency (1)		2.1	%		—		2.7	%		2.3%-3.1%
•	Revenue for the fourth fiscal quarter of 2024 was slightly above the midpoint of Amdocs’ guidance, adjusting<br>for positive impact from foreign currency movements of approximately $3 million relative to our guidance assumptions and relative to the third quarter of fiscal 2024
---	---
•	Revenue for the full year fiscal 2024 includes an unfavorable impact from foreign currency movements of<br>approximately 0.3% year-over-year
---	---

Net Income and Earnings Per Share

`	In thousands, expect per share data
	Three months ended				Twelve months ended
	September 30,				September 30,
	2024		2023		2024		2023
GAAP Measures
Net Income	$	87,176	$	102,666	$	496,321	$	542,962
Net Income attributable to Amdocs Limited	$	86,441	$	102,011	$	493,197	$	540,709
Diluted earnings per share	$	0.76	$	0.86	$	4.25	$	4.49
Non-GAAP Measures
Non-GAAP Net Income	$	195,668	$	169,009	$	750,928	$	714,454
Non-GAAP Net Income attributable to Amdocs<br>Limited	$	194,933	$	168,354	$	747,804	$	712,201
Non-GAAP Diluted earnings per share	$	1.70	$	1.42	$	6.44	$	5.91
•	Non-GAAP net income excludes amortization of purchased intangible assets<br>and other acquisition-related costs, changes in certain acquisition related liabilities measured at fair value, equity-based compensation expenses, restructuring charges, and other, net of related tax effects. For further details of the<br>reconciliation of selected financial metrics from GAAP to Non-GAAP, please refer to the tables below.
---	---

Capital Allocation

•	Quarterly Cash Dividend Program: On November 12, 2024, the Board approved the Company’s<br>next quarterly cash dividend payment of $0.479 per share, and set December 31, 2024 as the record date for determining the shareholders entitled to receive the dividend, which will be payable on January 31, 2025
•	The Board also approved a 10% increase in the Company’s quarterly cash dividend payment to $0.527 per share,<br>which is anticipated to be first paid in April 2025, provided that the increase is approved by shareholders at the January 2025 annual general meeting of shareholders
---	---
•	Share Repurchase Activity: Repurchased $120 million of ordinary shares during the fourth<br>quarter of fiscal 2024
---	---

Twelve-month Backlog

Twelve-month backlog was $4.06 billion at the end of the fourth quarter of fiscal 2024. On a pro forma^(2)^ basis, adjusting the comparable period for the phase out of certain business activities, twelve-month backlog was up approximately 2.5% as compared to last year’s fourth fiscal quarter. Twelve-month backlog includes anticipated revenue related to contracts, estimated revenue from managed services contracts, letters of intent, maintenance and estimated on-going support activities.

First Quarter Fiscal 2025 Outlook

	In millions, except pershare data
	Q1 – 2025
Revenue	$1,095-$1,135
GAAP Diluted earnings per share	$1.20-$1.29
Non-GAAP Diluted earnings per share	$1.61-$1.67
•	First quarter revenue guidance assumes favorable $2 million sequential impact from foreign currency<br>fluctuations as compared to the fourth quarter of fiscal 2024
---	---
•	First quarter non-GAAP diluted EPS guidance excludes primarily<br>equity-based compensation expense of approximately $0.20-$0.22 per share, amortization of purchased intangible assets and other acquisition-related costs of approximately $0.11 per share, changes in certain<br>acquisitions related liabilities measured at fair value, and other, net of related tax effects
---	---
•	GAAP diluted EPS guidance does not include the impact of future restructuring charges
---	---

Full Year Fiscal 2025 Outlook

	FY 2025, year-over-year growth
	Guidance
Revenue growth, as reported	(10.9)%-(7.7)%
Revenue growth, pro forma(2) constant currency(1)	1%-4.5%
GAAP diluted EPS growth	25.0%-33.0%
Non-GAAP diluted EPS growth	6.5%-10.5%
	FY 2025, in millions
---	---	---
	Guidance
Free cash flow(5)	$	710-$730
•	Revenue growth on a pro forma^(^^2)^, constant currency^(1)^ basis adjusts fiscal 2024 revenue by approximately $600 million to reflect the end of several low-margin, non-core business activities, including certain low-margin software and hardware partner activities, Vubiquity’s<br>transactional video on demand business and non-core subscription services; these activities substantially already ceased in the first quarter of fiscal 2025 and are not included in the full year fiscal 2025<br>revenue outlook
---	---
•	Full year fiscal 2025 revenue guidance incorporates an expected favorable impact from foreign currency<br>fluctuations of approximately 0.2% year-over-year, and includes some inorganic contribution
---	---
•	Non-GAAP diluted earnings per share growth excludes primarily<br>equity-based compensation expense of approximately $0.86-$0.94 per share, amortization of purchased intangible assets and other acquisition-related costs of approximately $0.43 per share, changes in certain<br>acquisitions related liabilities measured at fair value, and other, net of related tax effects
---	---
•	GAAP diluted EPS guidance does not include the impact of future restructuring charges
---	---
•	Non-GAAP operating margin is anticipated to be within a range of 21.1% to<br>21.7% for the full year fiscal 2025
---	---
•	Non-GAAP operating margin is comprised of GAAP operating margin,<br>excluding amortization on purchased intangible assets and other, equity-based compensation expense, restructuring charges, and changes in certain acquisitions related liabilities measured at fair value
---	---
•	Non-GAAP effective tax rate is anticipated to be within a range of 15% to<br>17% for the full year fiscal 2025
---	---
•	Free cash<br>flow^(^^5)^ is comprised of cash flow from operations, less net capital expenditures and other, and excludes payments related to restructuring<br>charges
---	---

The forward looking statements regarding our first fiscal quarter 2025 and full year fiscal 2025 guidance take into consideration the Company’s current expectations regarding macro and industry specific risks and various uncertainties and certain assumptions that we will discuss on our earnings conference call. However, we note that market dynamics continue to shift rapidly and we cannot predict all possible outcomes, including those resulting from certain geopolitical events, the current inflationary environment, global or regional events, and the prevailing level of macro-economic, business and operational uncertainty, which have created, and continue to create, a significant amount of uncertainty, or from current and potential customer consolidation or their other strategic corporate activities.

Conference Call and Earnings Webcast Presentation Details

Amdocs will host a conference call and earnings webcast presentation on November 12, 2024 at 5:00 p.m. Eastern Time to discuss the Company’s fourth quarter of fiscal 2024 results.

To participate in the call, please register here to receive the dial-in numbers and unique access PIN. The conference call and webcast will also be carried live on the Internet and may be accessed via the Amdocs website at https://investors.amdocs.com. Presentation slides will be available shortly before the webcast.

Non-GAAP Financial Measures

This release includes non-GAAP diluted earnings per share and other non-GAAP financial measures, including free cash flow, revenue on a constant currency^(1)^ basis, non-GAAP cost of revenue, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP interest and other expenses, net, non-GAAP income taxes, non-GAAP effective tax rate, non-GAAP net income, non-GAAP net income attributable to Amdocs Limited and non-GAAP diluted earnings per share growth. These other non-GAAP measures exclude the following items:

•	amortization of purchased intangible assets and other acquisition-related costs;
•	changes in certain acquisition-related liabilities measured at fair value;
---	---
•	restructuring and unusual charges or benefits;
---	---
•	equity-based compensation expense;
---	---
•	other; and
---	---
•	tax effects related to the above.
---	---

Free cash flow equals cash generated by operating activities less net capital expenditures and other. These non-GAAP financial measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP financial measures used by other companies. In addition, these non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles. Amdocs believes that non-GAAP financial measures have limitations in that they do not reflect all of the amounts associated with Amdocs’ results of operations as determined in accordance with GAAP and that these measures should only be used to evaluate Amdocs’ results of operations in conjunction with the corresponding GAAP measures.

Amdocs believes that the presentation of non-GAAP diluted earnings per share and other financial measures, including free cash flow^(5)^, revenue on a constant currency^(1)^ basis, non-GAAP cost of revenue, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP interest and other expenses, net, non-GAAP income taxes, non-GAAP effective tax rate, non-GAAP net income, non-GAAP net income attributable to Amdocs Limited and non-GAAP diluted earnings per share growth when shown in conjunction with the corresponding GAAP measures, provides useful information to investors and management regarding financial and business trends relating to its financial condition and results of operations, as well as the net amount of cash generated by its business operations after taking into account capital spending required to maintain or expand the business.

For its internal budgeting process and in monitoring the results of the business, Amdocs’ management uses financial statements that do not include amortization of purchased intangible assets and other acquisition-related costs, changes in certain acquisition-related liabilities measured at fair value, restructuring and unusual charges or benefits, equity-based compensation expense, other and related tax effects. Amdocs’ management also uses the foregoing non-GAAP financial measures, in addition to the corresponding GAAP

measures, in reviewing the financial results of Amdocs. In addition, Amdocs believes that significant groups of investors exclude these items in reviewing its results and those of its competitors, because the amounts of the items between companies can vary greatly depending on the assumptions used by an individual company in determining the amounts of the items.

Amdocs further believes that, where the adjustments used in calculating non-GAAP diluted earnings per share are based on specific, identified amounts that impact different line items in the Consolidated Statements of Income (including cost of revenue, research and development, selling, general and administrative, operating income, interest and other expenses, net, income taxes and net income), it is useful to investors to understand how these specific line items in the Consolidated Statements of Income are affected by these adjustments. Please refer to the Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP tables below.

Supporting Resources

•	Keep up with Amdocs news by visiting the Company’s website
•	Subscribe to Amdocs’ RSS Feed and follow us on Twitter, Facebook, LinkedIn and<br>YouTube
---	---

About Amdocs

Amdocs helps those who build the future to make it amazing. With our market-leading portfolio of software products and services, we unlock our customers’ innovative potential, empowering them to provide next-generation communication and media experiences for both the individual end user and large enterprise customers. Our employees around the globe are here to accelerate service providers’ migration to the cloud, enable them to differentiate in the 5G era, and digitalize and automate their operations. Listed on the NASDAQ Global Select Market, Amdocs had revenue of $5.00 billion in fiscal 2024.

For more information, visit Amdocs at www.amdocs.com.

This press release includes information that constitutes forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995, including statements about Amdocs’ growth and business results in future quarters and years. Although we believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations will not be material. Such statements involve risks and uncertainties that may cause future results to differ from those anticipated. These risks include, but are not limited to, the effects of general macroeconomic conditions, prevailing level of macroeconomic, business and operational uncertainty, including as a result of geopolitical events or other regional events, as well as the current inflationary environment, and the effects of these conditions on the Company’s customers’ businesses and levels of business activity, including the effect of the current economic uncertainty and industry pressure on the spending decisions of the Company’s customers. Amdocs’ ability to grow in the business markets that it serves, Amdocs’ ability to successfully integrate acquired businesses, adverse effects of market competition, rapid technological shifts that may render the Company’s products and services obsolete, potential loss of a major customer, our ability to develop long-term relationships with our customers, our ability to successfully and effectively implement artificial intelligence and Generative AI in the Company’s offerings and operations, and risks associated with operating businesses in the international market. Amdocs may elect to update these forward-looking statements at some point in the future; however, Amdocs specifically disclaims any obligation to do so. These and other risks are discussed at greater length in Amdocs’ filings with the Securities and Exchange Commission, including in our Annual Report on Form 20-F for the fiscal year ended September 30, 2023 filed on December 13, 2023 and our Form 6-K furnished for the first quarter of fiscal 2024 on February 20, 2024, the second quarter of fiscal 2024 filed on May 20, 2024 and for the third quarter of fiscal 2024 on August 19, 2024.

Contact:

Matthew Smith

Head of Investor Relations

Amdocs

314-212-8328

E-mail: dox_info@amdocs.com

AMDOCS LIMITED

Consolidated Statements of Income

(In thousands, except per share data)

	Three months ended<br>September 30,						Fiscal year ended<br>September 30,
	2024			2023			2024			2023
Revenue	$	1,263,882		$	1,242,564		$	5,004,989		$	4,887,550
Operating expenses:
Cost of revenue		824,888			803,600			3,249,598			3,159,941
Research and development		90,069			97,693			360,798			374,855
Selling, general and administrative		138,705			140,380			572,845			570,707
Amortization of purchased intangible assets and other		14,333			15,601			62,052			57,156
Restructuring charges		83,213			46,365			131,088			70,901
		1,151,208			1,103,639			4,376,381			4,233,560
Operating income		112,674			138,925			628,608			653,990
Interest and other expense, net		(9,237	)		(5,307	)		(37,537	)		(17,629	)
Income before income taxes		103,437			133,618			591,071			636,361
Income taxes		16,261			30,952			94,750			93,399
Net income	$	87,176		$	102,666		$	496,321		$	542,962
Net income attributable to noncontrolling interests		735			655			3,124			2,253
Net income attributable to Amdocs Limited	$	86,441		$	102,011		$	493,197		$	540,709
Basic earnings per share attributable to Amdocs Limited	$	0.76		$	0.86		$	4.27		$	4.52
Diluted earnings per share attributable to Amdocs Limited	$	0.76		$	0.86		$	4.25		$	4.49
Basic weighted average number of shares outstanding		113,745			118,076			115,489			119,687
Diluted weighted average number of shares outstanding		114,378			118,884			116,145			120,519
Cash dividends declared per share	$	0.479		$	0.435		$	1.872		$	1.700

AMDOCS LIMITED

Selected Financial Metrics

(In thousands, except per share data)

	Three months ended<br>September 30,				Fiscal year ended<br>September 30,
	2024		2023		2024		2023
Revenue	$	1,263,882	$	1,242,564	$	5,004,989	$	4,887,550
Non-GAAP operating income		236,223		221,105		923,288		868,602
Non-GAAP net income		195,668		169,009		750,928		714,454
Non-GAAP net income attributable to Amdocs<br>Limited		194,933		168,354		747,804		712,201
Non-GAAP diluted earnings per share	$	1.70	$	1.42	$	6.44	$	5.91
Diluted weighted average number of shares outstanding		114,378		118,884		116,145		120,519

Free Cash Flows

(In thousands)

	Three months ended<br>September 30,						Fiscal year ended<br>September 30,
	2024			2023			2024			2023
Net Cash Provided by Operating Activities	$	217,922		$	272,371		$	724,428		$	822,630
Purchases of property and equipment, net (a)		(25,812	)		(26,557	)		(105,495	)		(124,362	)
Free Cash Flow	$	192,110		$	245,814		$	618,933		$	698,268
(a)	The amounts under “Purchase of property and equipment, net” include immaterial proceeds from sale of<br>property and equipment for the fiscal years ended September 30, 2024 and 2023, respectively.
---	---

AMDOCS LIMITED

Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP

(In thousands)

	Three Months Ended September 30, 2024
	GAAP			Amortizationof purchasedintangibleassets andother			Equity basedcompensationexpense			Restructuringcharges			Other		Tax<br>effect			Non-GAAP
Operating expenses:
Cost of revenue	$	824,888		$	—		$	(13,283	)	$	—		$	—	$	—		$	811,605
Research and development		90,069						(2,355	)										87,714
Selling, general and administrative		138,705						(10,365	)										128,340
Amortization of purchased intangible assets and other		14,333			(14,333	)													—
Restructuring charges		83,213									(83,213	)							—
Total operating expenses		1,151,208			(14,333	)		(26,003	)		(83,213	)							1,027,659
Operating income		112,674			14,333			26,003			83,213								236,223
Interest and other expense, net		(9,237	)											2,549					(6,688	)
Income taxes		16,261														17,606			33,867
Net income		87,176			14,333			26,003			83,213			2,549		(17,606	)		195,668
Net income attributable to noncontrolling interests		735																	735
Net income attributable to Amdocs Limited	$	86,441		$	14,333		$	26,003		$	83,213		$	2,549	$	(17,606	)	$	194,933
	Three Months Ended September 30, 2023
---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---
	GAAP			Amortizationof purchasedintangibleassets andother			Equity basedcompensationexpense			Changes incertainacquisitionsrelatedliabilitiesmeasuredat fairvalue			Restructuringcharges			Other		Tax<br>effect			Non-GAAP
Operating expenses:
Cost of revenue	$	803,600		$	—		$	(12,401	)	$	4,579		$	—		$	—	$	—		$	795,778
Research and development		97,693						(2,285	)													95,408
Selling, general and administrative		140,380						(10,107	)													130,273
Amortization of purchased intangible assets and other		15,601			(15,601	)																—
Restructuring charges		46,365												(46,365	)							—
Total operating expenses		1,103,639			(15,601	)		(24,793	)		4,579			(46,365	)							1,021,459
Operating income		138,925			15,601			24,793			(4,579	)		46,365								221,105
Interest and other expense, net		(5,307	)														398					(4,909	)
Income taxes		30,952																	16,235			47,187
Net income		102,666			15,601			24,793			(4,579	)		46,365			398		(16,235	)		169,009
Net income attributable to noncontrolling interests		655																				655
Net income attributable to Amdocs Limited	$	102,011		$	15,601		$	24,793		$	(4,579	)	$	46,365		$	398	$	(16,235	)	$	168,354

AMDOCS LIMITED

Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP

(In thousands)

	Fiscal year ended September 30, 2024
	GAAP			Amortizationof purchasedintangibleassets andother			Equity basedcompensationexpense			Changes incertainacquisitionsrelatedliabilitiesmeasuredat fairvalue			Restructuringcharges			Other		Tax<br>effect			Non-GAAP
Operating expenses:
Cost of revenue	$	3,249,598		$	—		$	(53,409	)	$	3,000		$	—		$	—	$	—		$	3,199,189
Research and development		360,798						(8,644	)													352,154
Selling, general and administrative		572,845						(42,487	)													530,358
Amortization of purchased intangible assets and other		62,052			(62,052	)																—
Restructuring charges		131,088												(131,088	)							—
Total operating expenses		4,376,381			(62,052	)		(104,540	)		3,000			(131,088	)							4,081,701
Operating income		628,608			62,052			104,540			(3,000	)		131,088								923,288
Interest and other expense, net		(37,537	)														8,087					(29,450	)
Income taxes		94,750																	48,160			142,910
Net income		496,321			62,052			104,540			(3,000	)		131,088			8,087		(48,160	)		750,928
Net income attributable to noncontrolling interests		3,124																				3,124
Net income attributable to Amdocs Limited	$	493,197		$	62,052		$	104,540		$	(3,000	)	$	131,088		$	8,087	$	(48,160	)	$	747,804
	Fiscal year ended September 30, 2023
---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---
	GAAP			Amortizationof purchasedintangibleassets andother			Equity basedcompensationexpense			Changes incertainacquisitionsrelatedliabilitiesmeasuredat fairvalue			Restructuringcharges			Other		Tax<br>effect			Non-GAAP
Operating expenses:
Cost of revenue	$	3,159,941		$	—		$	(42,969	)	$	3,143		$	—		$	—	$	—		$	3,120,115
Research and development		374,855						(7,509	)													367,346
Selling, general and administrative		570,707						(39,220	)													531,487
Amortization of purchased intangible assets and other		57,156			(57,156	)																—
Restructuring charges		70,901												(70,901	)							—
Total operating expenses		4,233,560			(57,156	)		(89,698	)		3,143			(70,901	)							4,018,948
Operating income		653,990			57,156			89,698			(3,143	)		70,901								868,602
Interest and other expense, net		(17,629	)														906					(16,723	)
Income taxes		93,399																	44,026			137,425
Net income		542,962			57,156			89,698			(3,143	)		70,901			906		(44,026	)		714,454
Net income attributable to noncontrolling interests		2,253																				2,253
Net income attributable to Amdocs Limited	$	540,709		$	57,156		$	89,698		$	(3,143	)	$	70,901		$	906	$	(44,026	)	$	712,201

AMDOCS LIMITED

Condensed Consolidated Balance Sheets

(In thousands)

	As of
	September 30,<br>2024		September 30,<br>2023
ASSETS
Current assets:
Cash and cash equivalents	$	346,085	$	520,080
Short-term interest-bearing investments		168,242		222,451
Accounts receivable, net, including unbilled		1,028,357		944,477
Prepaid expenses and other current assets		228,498		224,622
Total current assets		1,771,182		1,911,630
Property and equipment, net		755,601		790,923
Lease assets		149,254		160,938
Goodwill and other intangible assets, net		3,005,637		2,930,580
Other noncurrent assets		704,468		631,582
Total assets	$	6,386,142	$	6,425,653
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities
Accounts payable, accruals and other	$	1,315,679	$	1,142,781
Lease liabilities		39,983		39,960
Deferred revenue		115,247		170,634
Total current liabilities		1,470,909		1,353,375
Lease liabilities		103,462		121,654
Long-term debt, net of unamortized debt issuance costs		646,291		645,696
Other noncurrent liabilities		666,303		737,996
Total Amdocs Limited Shareholders’ equity		3,456,976		3,523,759
Noncontrolling interests		42,201		43,173
Total equity		3,499,177		3,566,932
Total liabilities and equity	$	6,386,142	$	6,425,653

AMDOCS LIMITED

Consolidated Statements of Cash Flows

(In thousands)

	Fiscal year ended<br>September 30,
	2024			2023
Cash Flow from Operating Activities:
Net income	$	496,321		$	542,962
Reconciliation of net income to net cash provided by operating activities:
Depreciation, amortization and impairment		193,066			195,701
Amortization of debt issuance cost		596			579
Equity-based compensation expense		104,540			89,698
Deferred income taxes		(45,673	)		(60,212	)
Loss from short-term interest-bearing investments		5,576			2,762
Net changes in operating assets and liabilities, net of amounts acquired:
Accounts receivable, net		(104,413	)		3,457
Prepaid expenses and other current assets		(8,478	)		7,891
Other noncurrent assets		(2,250	)		(1,532	)
Lease assets and liabilities, net		(6,485	)		(4,144	)
Accounts payable, accrued expenses and accrued personnel		216,324			158,876
Deferred revenue		(60,332	)		(157,829	)
Income taxes payable, net		(47,241	)		(11,596	)
Other noncurrent liabilities		(17,123	)		56,017
Net cash provided by operating activities		724,428			822,630
Cash Flow from Investing Activities:
Purchase of property and equipment, net(a)		(105,495	)		(124,362	)
Proceeds from sale of short-term interest-bearing investments		68,659			25,984
Purchase of short-term interest-bearing investments		(9,061	)		—
Net cash paid for business and intangible assets acquisitions		(86,824	)		(121,818	)
Other		5,315			(4,301	)
Net cash used in investing activities		(127,406	)		(224,497	)
Cash Flow from Financing Activities:
Repurchase of shares		(563,121	)		(489,524	)
Proceeds from employee stock option exercises		26,949			48,681
Payments of dividends		(211,967	)		(199,460	)
Distribution to noncontrolling interests		(4,096	)		(1,589	)
Payment of contingent consideration from a business acquisition		(18,782	)		(9,538	)
Net cash used in financing activities		(771,017	)		(651,430	)
Net decrease in cash and cash equivalents		(173,995	)		(53,297	)
Cash and cash equivalents at beginning of year		520,080			573,377
Cash and cash equivalents at end of year	$	346,085		$	520,080

AMDOCS LIMITED

Supplementary Information

(In millions)

	Three months ended
	September 30,2024		June 30,2024		March 31,2024		December 31,2023		September 30,2023
North America	$	835.8	$	828.8	$	823.2	$	838.1	$	834.4
Europe		184.1		175.9		184.8		181.4		175.5
Rest of the World		244.0		245.3		237.8		225.7		232.6
Total Revenue	$	1,263.9	$	1,250.1	$	1,245.8	$	1,245.2	$	1,242.6
	Three months ended
	September 30,2024		June 30,2024		March 31,2024		December 31,2023		September 30,2023
Managed Services Revenue	$	721.4	$	740.8	$	720.3	$	722.5	$	718.1
	As of
	*September 30,2024 ()**		June 30,2024		March 31,2024		December 31,2023		September 30,2023
12-Month Backlog	$	4,060	$	4,250	$	4,230	$	4,210	$	4,150
(*)	Excluding the phase out of certain business activities in the fourth fiscal quarter of 2024 only<br>
---	---

# # #

EX-99.2

Exhibit 99.2 Amdocs Limited NASDAQ: DOX Fiscal Q4 2024 Earnings Presentation November 12, 2024 Shuky Sheffer President & CEO Tamar Rapaport-Dagim CFO & COO

The information contained herein in this presentation or delivered or to be delivered to you during this presentation does not constitute an offer, expressed or implied, or a recommendation to do any transaction in Amdocs Limited securities or in any securities of its affiliates or subsidiaries. This presentation and the comments made by members of Amdocs management in conjunction with it can be found on the Investor Relations section of our website, and, as always, a copy of today’s prepared remarks will also be posted immediately following the conclusion of this call. This presentation includes information that constitutes forward- looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995, including statements about Amdocs’ growth and business results in future quarters and years. Although we believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations will not be material. Such statements involve risks and uncertainties that may cause future results to differ from those anticipated. These risks include, but are not limited to, the effects of general macroeconomic conditions, prevailing level of macroeconomic, business and operational uncertainty, including as a result of geopolitical events or other regional events, as well as the current inflationary environment, and the effects of these conditions on the Company’s customers’ businesses and levels of business activity, including the effect of the current economic uncertainty and industry pressure on the spending decisions of the Company’s customers. Amdocs’ ability to grow in the business markets that it serves, Amdocs’ ability to successfully integrate acquired businesses, adverse effects of market competition, rapid technological shifts that may render the Company’s products and services obsolete, potential loss of a major customer, our ability to develop long-term relationships with our customers, our ability to successfully and effectively implement artificial intelligence and Generative AI in the Company’s offerings and operations, and risks associated with operating businesses in the international market. Amdocs may elect to update these forward-looking statements at some point in the future; however, Amdocs specifically disclaims any obligation to do so. These and other risks are discussed at greater length in Amdocs’ filings with the Securities and Exchange Commission, including in our Annual Report on Form 20-F for the fiscal year ended September 30, 2023, filed on December 13, 2023, and our Form 6-K furnished for the first quarter of fiscal 2024 on February 20, 2024, the second quarter of fiscal 2024 on May 20, 2024, and for the third quarter of fiscal 2024 on August 19, 2024. This presentation includes non-GAAP financial measures, including non-GAAP operating margin, free cash flow, revenue on a constant currency basis, non-GAAP net income, non-GAAP net income attributable to Amdocs Limited, and non-GAAP earnings per share. Free cash flow equals cash generated by operating activities less net capital expenditures and other. While in prior years Amdocs used normalized free cash flow, a measure of our operating performance, is further adjusted to exclude net capital expenditures related to the new campus development, payments for non-recurring and unusual charges (such as capital gains tax to be paid in relation to the divestiture of OpenMarket), and payments of acquisition related liabilities, Amdocs is no longer reporting normalized free cash flow. Normalized free cash flow is not comparable to free cash flow. These non-GAAP financial measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP financial measures used by other companies. In addition, these non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles. Amdocs believes that non-GAAP financial measures have limitations in that they do not reflect all of the amounts associated with Amdocs’ results of operations as determined in accordance with GAAP and that these measures should only be used to evaluate Amdocs’ results of operations in conjunction with the corresponding GAAP measures. Please refer to the appendix for a reconciliation of these metrics to the most comparable GAAP provision. This presentation also includes pro forma metrics which exclude the financial impact of OpenMarket (divested on December 31, 2020) from fiscal year 2021. Please also review the information contained in Amdocs’ press release dated November 12, 2024 with respect to earnings for fiscal Q4 2024. The press release contains additional information regarding Amdocs’ outlook for fiscal year 2025 and certain non-GAAP metrics and their reconciliations. Information Security Level 0 – Public. © 2024 – Proprietary & Confidential Information of Amdocs 2

Earnings call agenda 1 Strategy & business performance update Shuky Sheffer, President & Chief Executive Officer 2 Financial review & outlook Tamar Rapaport-Dagim, Chief Financial Officer & Chief Operating Officer 3 Q&A Information Security Level 0 – Public. © 2024 – Proprietary & Confidential Information of Amdocs 3 3 3

Today’s speakers President & Chief Executive Officer Chief Financial Officer & Chief Operating Officer Information Security Level 0 – Public. © 2024 – Proprietary & Confidential Information of Amdocs 4 4

President & Chief Executive Officer Strategy and business performance update 5

Fiscal 2024, Another Important Year For Amdocs Thanks to our amazing people for delivering value with innovative products & services Important wins, expanding Double-digit growth in cloud, market presence now ~25% of revenue Another record year in Accelerated managed services profitability Returned over 100% of free cash Extended industry-leading flow to shareholders position in GenAI Information Security Level 0 – Public. © 2024 – Proprietary & Confidential Information of Amdocs 6

FY24: Record Annual Revenue, Continued Profitable Growth & Margin Improvement Non-GAAP Non-GAAP 12-month (1) Revenue operating (2) EPS backlog (2) margin 18.4% $6.44 $5,005m $4.06B (1) (3) (2) Up 2.7% YoY +60bps YoY Up 2.5% YoY Up 9.0% YoY Record total revenue Cloud Improved profitability as In line with mid-point of On a pro-forma basis, as ~25% of revenue, growing operational efficiencies updated FY24 outlook we reinforce our business double-digits benefits realized visibility and focus 1. Constant currency. Assumes exchange rates in the current period were unchanged from the prior period 2. Non-GAAP. See reconciliation tables in appendix 3. Pro forma excludes the financial impact resulting from the phase out of certain business activities in the current fiscal year period and comparable fiscal year period Information Security Level 0 – Public. © 2024 – Proprietary & Confidential Information of Amdocs Information Security Level 0 – Public. © 2024 – Proprietary & Confidential Information of Amdocs 7 7

Q4 Key Highlights Strong sales momentum Important win at T-Mobile Maintained high managed in cloud services renewal rate Next-gen monetization platform Tier 1 operator Southeast Asia Italy Japan New pillar, part ofMulti- year digital transformation program Rapid adoption of Progressing GenAI Continued successful track Amdocs SaaS industry leadership record of project deployments connectX platform Major deployments: UAE * Poland UK Bulgaria Philippines South Africa Information Security Level 0 – Public. © 2024 – Proprietary & Confidential Information of Amdocs * referenced last quarter as a leading global operator 8 8

Strategic Growth Framework Designed to provide the market-leading innovation our customers need Accelerate the journey to the cloud Digitally transform the customer experience for consumer and B2B Monetize the future market potential of next-generation networks Deliver dynamic connected experiences by streamlining and automating complex network ecosystems Simplify and accelerate the adoption of Generative AI IIn nf for orm ma at tiion on Se Sec cu ur riit ty y L Le evel vel 0 0 – – P Pu ub blliic c. . © © 20 2024 24 – – P Pr rop opr riie et ta ar ry y & & Con Conf fiid de en nt tiia all IIn nf for orm ma at tiion on of of A Am md doc ocs s 9 9 9

Progress in Strategic Domains - Cloud Strong Accelerate the journey to the cloud partnerships Selected projects Business value Business platform modernization and cloud Faster, high-quality, and next-generation services Italy migration under 5-year agreement and customer experience, enhance operational efficiency, and reduce costs Modernize and migrate core systems to the Enable greater cost control, increased cloud under business transformation and efficiency and improved business capabilities InfraNet managed services agreement Japan Our strong book of business and healthy pipeline of opportunities supports another year of double-digit cloud growth in FY25 IIn nf for orm ma at tiion on Se Sec cu ur riit ty y L Le evel vel 0 0 – – P Pu ub blliic c. . © © 20 2024 24 – – P Pr rop opr riie et ta ar ry y & & Con Conf fiid de en nt tiia all IIn nf for orm ma at tiion on of of A Am md doc ocs s 10 10

Progress in Strategic Domains - Monetization of Next Generation Networks Monetize the future market potential of next-generation networks Selected projects Business value Real time monetization solution, new Enables customers the freedom to define their buying pillar part of multi-year digital experience while delivering complete business flexibility transformation program on a single all-inclusive platform New next-generation fiber solution introduced Unlocks significant savings and additional monetization Transformation of mobile and fixed-line potential and enabling enhanced customer experience B2C billing systems Information Security Level 0 – Public. © 2024 – Proprietary & Confidential Information of Amdocs 11

Progress in Strategic Domains – Digital Modernization Digitally transform the customer experience for consumer and B2B Strong traction in our SaaS next-gen platforms Amdocs’ cloud-native Adding to the growing list of customers A Poland ‘telco in a box’ SaaS platform Brazil Enables quick launch of new digital brands and services Vietnam US South Africa SaaS-based Bill Experience Adding to the growing list of customers B including tier 1 customer in North Global leader in Enables streamline billing commercial America experience and enhances payments customer satisfaction IIn nf for orm ma at tiion on Se Sec cu ur riit ty y L Le evel vel 0 0 – – P Pu ub blliic c. . © © 20 2024 24 – – P Pr rop opr riie et ta ar ry y & & Con Conf fiid de en nt tiia all IIn nf for orm ma at tiion on of of A Am md doc ocs s 12

Progress in Strategic Domains - Network Automation Deliver dynamic connected experiences by streamlining and automating complex network ecosystems Selected project Business value Leading US provider of Next-generation fiber rollout Accelerate sales, enhance agility, and realize fiber optic internet new monetization opportunities services Introduced Next-Generation Fiber Offering to Accelerate and streamline fiber deployment 30% faster deployments 10%+ reduction of cabling Significant reduction in network times for fiber rollouts and trenching management costs Best-in-class, award-winning offerings IIn nf for orm ma at tiion on Se Sec cu ur riit ty y L Le evel vel 0 0 – – P Pu ub blliic c. . © © 20 2024 24 – – P Pr rop opr riie et ta ar ry y & & Con Conf fiid de en nt tiia all IIn nf for orm ma at tiion on of of A Am md doc ocs s 13 13

Progress in strategic domains – GenAI An industry leader in helping service providers unlock the transformative potential of Gen AI CES24 - New Copilots amAIz expands with more Platform updates to utilized at customers data & AI platform agent capabilities Simplifying GenAI adoption with our industry- leading platform & robust, end-to-end data & AI services Bill Customer Inquiry Care Spectrum Knowledge Management Management Philippines UAE * Data intelligence DataONE amAIz platform IIn nf for orm ma at tiion on Se Sec cu ur riit ty y L Le evel vel 0 0 – – P Pu ub blliic c. . © © 20 2024 24 – – P Pr rop opr riie et ta ar ry y & & Con Conf fiid de en nt tiia all IIn nf for orm ma at tiion on of of A Am md doc ocs s 14 14 * referenced last quarter as a leading global operator

Sharpening Focus on Strategic Priorities in FY25 Reinforce level of business visibility Focus on strategic Increase share of highly recurring priorities long-term managed services agreements phasing out of several low-margin, non-core business activities Sharpen our focus on higher-margin strategic priorities like cloud, next-gen monetization platforms and Gen AI IIn nf for orm ma at tiion on Se Sec cu ur riit ty y L Le evel vel 3 0 – – P Hu igh blilc y . s© e n 20 sit24 ive. – © Pr op 2024 rie t– a P ry rop & rCon ietarfy id & enCon tial Ifn id for en m tia at l ion Infor of m A am tion doc of s Amdocs 15 15 15

FY25 Outlook A B 1%-4.5% earning-to-cash flow YoY growth (1,2) conversion Revenue Adjusting for the phase out of several low- Free cash margin, non-core business activities Expect to return majority flow of free cash flow to Double-digit cloud shareholders in year ahead revenue growth in FY25 C D 21.1% - 21.7% 6.5%-10.5% % margin YoY growth Non-GAAP Non-GAAP Expect to deliver accelerated YoY Positions us to deliver double-digit (3) (3) EBIT profitability improvement, EPS expected total shareholder leveraging our platform, technology and (3) returns in fiscal 2025 IP-based innovation We are positioned to deliver double-digit expected total (4) th shareholder returns for the 5 straight year in FY 2025 3. Non-GAAP. See reconciliation tables in appendix 1. Constant currency. Assumes exchange rates in the current period were unchanged from the prior period 2. For comparison purposes, pro forma adjusts fiscal 2024 revenue by approximately $600 million to reflect the 4. Expected total shareholder return assumes Non-GAAP EPS growth plus dividend yield (based on fiscal year end closing share price); FY2025E end of certain low margin, non-core business activities which substantially already ceased in the first quarter assumed midpoint of pro forma non-GAAP EPS outlook, and dividend yield of fiscal 2025 and are not included in the full year fiscal 2025 revenue outlook based on proposed new quarterly rate of $0.527 as of share price on 11/11/24 Information Security Level 0 – Public. © 2024 – Proprietary & Confidential Information of Amdocs 16 16

Chief Financial Officer & Chief Operating Officer Financial review & outlook 17

Q4 2024 Revenue vs. Guidance Q4 2024 Results Q4 FY2024 $ Millions Revenue slightly above guidance midpoint, adjusting for positive $3M Q4 Revenue currency impact Financial $1,264 million (1) +1.7% YoY, +2.1% constant currency $1,260 $1,264 Highlights Slightly above guidance midpoint ($1,240M - $1,280M) Record revenue, +1.7% YoY as reported Original Q4F24 Q4F24A (1) (2) and +2.1% YoY constant currency Q4 Non-GAAP Operating Margin Guidance (midpoint) 18.7%, +90bps YoY Record revenue in North America, up +0.8% QoQ and +0.2% YoY +10 bps QoQ Q4 2024 Revenue by Region $ Millions Europe up ~5% YoY and QoQ, as new Q4 GAAP Diluted EPS project activity ramps-up Rest of World $0.76 including a restructuring Rest of World up ~5% YoY ~$245 charge of 64 cents, without which EPS was at the higher end of ~19% Highest operating profitability in years, North guidance ($1.34 - $1.42) reflecting operational excellence and America cumulative benefits of automation, AI, Gen Europe ~15% ~$836 ~66% AI, and other sophisticated tools (2) ~$184 Q4 Non-GAAP Diluted EPS $1.70 at guidance midpoint 1. Constant currency. Assumes exchange rates in the current period were unchanged from the prior period ($1.67 - $1.73) 2. Non-GAAP. See reconciliation tables in appendix Information Security Level 2 – Sensitive. © 2024 – Proprietary & Information Security Level 0 – Public. © 2024 – Proprietary & Confidential Information of Amdocs 18 18 Confidential Information of Amdocs

Revenue Growth (2) Full Year Y/Y% growth constant currency (1) (2) Strong double-digit growth in FY2021 & FY2022 are pro forma constant currency Cloud, equating to roughly Fiscal 2024 10.3% 25% of total revenue +2.7% - in line with 7.7% 7.0% guidance midpoint Highlights Year-over-year growth and 2.7% record revenue across all operating regions: Record revenue of $5B, +2.4% YoY as reported and +2.7% YoY • North America: +0.6% YoY FY2021 FY2022 FY2023 FY2024 (1) • Europe: +3.3% YoY constant currency • Rest of World: +8.6% YoY Achieved accelerated (3) Non-GAAP EPS Y/Y % Growth profitability improvement target: 2 of top 10 customers are (1) FY2021 & FY2022 are pro forma (2) new logos added in last 10 +9.0% - in line with non-GAAP operating margin guidance midpoint years, highlighting ongoing 18.4%, +60 bps YoY in FY2024 12.1% 11.5% business diversification and 9.8% international market traction 9.0% (2) Record non-GAAP diluted EPS: $6.44, +9.0% YoY Number of countries with over $40M annual revenue has almost doubled in the 1. Constant currency. Assumes exchange rates in the last decade FY2021 FY2022 FY2023 FY2024 current period were unchanged from the prior period 2. Non-GAAP. See reconciliation tables in appendix Information Security Level 2 – Sensitive. © 2024 – Proprietary & Information Security Level 0 – Public. © 2024 – Proprietary & Confidential Information of Amdocs 19 19 Confidential Information of Amdocs

Managed Services Revenue: Fiscal Year Leading Indicators $ Billions 58% of FY 2024 revenue & Business Model Managed services arrangements support $2,905 $2,857 business model resiliency with highly Visibility recurring revenue streams, multi-year engagements and high renewal rates, and may also include large-scale digital Managed Services transformation projects FY2023 FY2024 ~58% of total revenue in FY 2024 Migration to Azure under an extended 5-year agreement, delivering faster, high-quality, next-gen services, enhancing efficiency, and reducing costs Expanded relationship to modernize and migrate core systems to the cloud, enabling greater cost control, increased efficiency and improved capabilities managed services Close to contract renewals 100% Extended managed services agreement for billing platform through 2032, enhancing operational efficiency and delivering more streamlined services Tier 1 Southeast Asia Signed an expanded multi-year engagement Information Security Level 2 – Sensitive. © 2024 – Proprietary & Information Security Level 0 – Public. © 2024 – Proprietary & Confidential Information of Amdocs 20 20 Confidential Information of Amdocs

(1) DSO’s FY 2024 Free cash flow bridge Balance Sheet 74 days FCF includes ~$75M +5 days YoY and unchanged QoQ restructuring payments DSO’s may fluctuate from quarter to quarter & Cash Flow ~$724 ~$105 The sequential quarter change in unbilled receivables net of deferred revenue was * $49 million in Q4, aggregating the short- $619 term and long-term balances (1) FY 2024 free cash flow of $694 The net difference between unbilled receivables million before ~$75 million of and deferred revenue fluctuates from quarter to Operating Cash Net capex & Other Reported FCF restructuring payments quarter, in line with normal business activities as well Flow as progress on significant multi-year transformation *Figures may not sum due to rounding programs we are currently running in North (1) America. FY 2024 reported free cash flow of Cash, Credit Facility & Debt Position $619 million including restructuring $ Millions, as of September 30, 2024 Liquidity: Cash + Credit Facility payments $1.0 billion Ample liquidity to support ongoing Credit business needs while retaining the Ample liquidity including available Facility $500 capacity to fund future strategic $500M revolving credit facility growth investments $650 Cash Baa1 BBB ~$514 Moody’s S&P 1. Non-GAAP. See reconciliation tables in appendix 2. $650M senior note, maturing June 2030 (2) Committed to maintaining our $0 Liquidity Debt Investment grade credit rating Information Security Level 2 – Sensitive. © 2024 – Proprietary & Information Security Level 0 – Public. © 2024 – Proprietary & Confidential Information of Amdocs 21 21 Confidential Information of Amdocs

Dividend Growth Q4 2024 Cash Returned to Shareholders $ Millions Board authorized new quarterly dividend Disciplined Capital payment: Dividends, 52.7 cents, +10% Allocation $55 12th consecutive annual dividend increase (1) Expects FY 2025 free cash flow (FCF) of New payment subject to shareholder approval between $710-$730M before Share at Amdocs annual meeting in January 2025, repurchases, restructuring payments, equating to >90% with first payment anticipated in April 2025 $120 cash conversion ~$0.5B of aggregate share repurchase authorization available as of September 30, 2024 (2) 6.8% free cash flow yield FCF: Five-year historical trend and FY2025E outlook (1)(3)(4)(5)(6)(7) Expects to return the majority of free cash 140% 102% 101% >90% flow to shareholders in FY2025 93% (1)(3)(5)(6) 88% % FCF / (1) Non-GAAP Net Income FY2025E 112% 104% 100% 99% guidance: 96% (1)(3)(5)(6) % of FCF Returned to return 1. Non-GAAP. See appendix tables for reconciliation of FCF Shareholders 2. Yield = expected reported free cash flow of $720M, the mid point of FY2025 majority guidance, as a percentage of Amdocs’ market capitalization as of 11/12/2024 3. FCF in FY2020, FY2021 and FY2022 is presented on a normalized basis, which mainly excludes net capital expenditures related to the new campus development; normalized FCF disclosure is not applicable as of FY2023 onward $869 (1)(3)(5)(6)(7) 4. Refer to https://investors.amdocs.com/ and earnings reports issued on 11/2/2021 FCF ($M) $718 $720 $694 $665 and 11/8/2022 for reconciliation of normalized FCF in FY2020, FY2021 and FY2022 $527 5. FY2023 excludes $20M non-recurring restructuring payments 6. FY2024 excludes $75M non-recurring restructuring payments 7. FY2025 assumes midpoint of $710-$730M guidance range, before non-recurring FY2020 FY2021 FY2022 FY2023 FY2024 FY2025E restructuring payments (Guidance) (1)(3) Information Security Level 2 – Sensitive. © 2024 – Proprietary & Normalized Information Security Level 0 – Public. © 2024 – Proprietary & Confidential Information of Amdocs 22 22 Confidential Information of Amdocs

Sharpening Focus on Strategic Priorities in FY25 Activities we are phasing out: Certain low-margin software and hardware partner activities ✓ Phase out of some on-premise software and hardware infrastructure ✓ Other legacy-type activities ✓ More focus on cloud-related infrastructure, and Gen AI partner infrastructure Vubiquity on demand business ✓ Decreasing demand for transactional video Non-core subscription services Expect substantially improved profitability in FY25 Information Security Level 0 – Public. © 2024 – Proprietary & Confidential Information of Amdocs Information Security Level 3 – Highly sensitive. © 2024 – Proprietary & Confidential Information of Amdocs 23 23

12-Month Backlog Leading Indicators & Business Model Visibility Up YoY on a pro- 12-month backlog +2.5% YoY and (1) (1) +$30M QoQ on a pro forma basis as forma basis of September 30, 2024, (1) 12-month backlog represents ~90% of 12-month backlog includes: expected FY 2025 revenue, higher Anticipated revenue related to contracts than historical average of ~80% (1) Estimated revenue from managed services contracts Letters of intent Maintenance 1. Pro forma excludes financial impact of phasing out certain business Estimated ongoing support activities activities in the current fiscal year period and comparable fiscal year period Information Security Level 2 – Sensitive. © 2024 – Proprietary & Information Security Level 0 – Public. © 2024 – Proprietary & Confidential Information of Amdocs 24 24 Confidential Information of Amdocs

FY2025 Revenue Growth (3) YoY% Growth Constant Currency Revenue Growth Outlook (1) Pro forma revenue adjustment for phasing out certain business activities is 10.3% estimated at roughly $600 million, taking 4.5% 7.7% Expect 2.7% FY 2024 as the baseline 7.0% guidance midpoint Expects FY2025 revenue growth of 1%- (1) 2.7% 4.5% YoY on a pro forma constant 2.4% 1% (3) currency basis, including some non- (2)(3) (3) (3) (3) (3) (1) (2)(3) organic contribution FY2020 FY2021 FY2022 FY2023 FY2024 FY2025E Cloud positioned for another year of double-digit growth in FY2025E “Overall, we expect revenue growth of between 1% and 4.5% on a pro forma, constant currency basis in fiscal 2025, which does not include revenue from the 1. For comparison purposes, pro forma adjusts fiscal 2024 revenue by activities we are phasing out. The forecast growth rate midpoint is similar to the approximately $600 million to reflect the end of certain low margin, non- prior fiscal year, includes some inorganic contribution, and incorporates another core business activities which substantially already ceased in the first quarter of fiscal 2025 and are not included in the full year fiscal 2025 revenue year of double-digit growth in cloud” outlook 2. Pro forma metrics exclude the financial impact of OpenMarket (which was – Tamar Rapaport Dagim, Q4 FY 2024 Earnings Call, November 12, 2024 divested on December 31, 2020) from fiscal year 2021. 3. Constant currency. Assumes exchange rates in the current period were unchanged from the prior period Information Security Level 2 – Sensitive. © 2024 – Proprietary & Information Security Level 0 – Public. © 2024 – Proprietary & Confidential Information of Amdocs 25 25 Confidential Information of Amdocs

(1) (2) Annual Non-GAAP Operating Margin: FY2018 – FY2025E Enhanced $ Millions (1) FY2025E Non-GAAP Operating margin Profitability target range: 21.1%-21.7% 21.7% Improvement 21.1% (1) FY2025 non-GAAP operating margin +300 bps YoY in new and improved target range of at guidance 21.1%-21.7%, up 300 bps YoY at midpoint midpoint 18.7% Operational excellence, automation and 18.1% gradual implementation of Gen AI, will 18.4% 17.8% 17.5% support ongoing margin expansion of 17.8% 17.2% 17.6% 17.5% about 60-70 bps in FY 2025, assuming the 17.3% 17.3% 17.2% 16.5% midpoint of guidance Phase out of certain business activities expected to drive roughly 230 bps of improvement “Assuming the midpoint of our new fiscal 2025 guidance, we believe our focus on operational excellence, automation and the gradual implementation of Gen AI, will support ongoing FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025E margin expansion of about 60 to 70 basis points, similar to the size of margin improvement we 1. Non-GAAP. See reconciliation tables in appendix generated in fiscal 2024. The rest of the margin expansion in fiscal 2025 will result from the Guidance Range Non-GAAP Operating Margin 2. Refer to https://investors.amdocs.com/ and earnings reports issued phasing out of non-core, low-margin business activities” on 11/8/2018, 11/12/19, 11/10/20, 11/2/2021, 11/8/2022, 11/7/2023 and 11/12/2024 for reconciliation of non-GAAP operating margin – Tamar Rapaport Dagim, Q4 FY 2024 Earnings Call, November 12, 2024 in FY2018, FY2019, FY2020, FY2021, FY2022, FY2023 and FY2024 Information Security Level 2 – Sensitive. © 2024 – Proprietary & Information Security Level 0 – Public. © 2024 – Proprietary & Confidential Information of Amdocs 26 26 Confidential Information of Amdocs

(3)(4) Total Shareholder Return Targeting double-digit (2) Non-GAAP Diluted EPS Growth YoY % + Dividend Yield (1) expected total FY21 and FY22 non-GAAP EPS growth is presented pro forma (3) shareholder returns th for the 5th year running 5 consecutive year of double-digit expected total shareholder returns* in FY2025 in FY2025E 14.1% 13.6% 11.7% 11.3% 10.8%* 12.1% (2) 11.5% Expects non-GAAP EPS growth of 10.5% Expects 9.8% 6.5%-10.5% in FY2025E 9.0% 8.5% guidance 5.3% 6.5% midpoint 3.0% 1. Pro forma metrics exclude the financial impact of OpenMarket 2.4% 2.3% 2.3% 2.1% 2.0% 1.9% (which was divested on December 31, 2020) from fiscal year 2021. (1) (1) 2. Non-GAAP. See reconciliation tables in appendix FY2020 FY2021 FY2022 FY2023 FY2024 FY2025E 3. Expected total shareholder return assumes Non-GAAP EPS growth plus dividend yield (based on fiscal year end closing share price); Non-GAAP Diluted EPS Growth Dividend Yield Total Shareholder Return FY2025E assumed 8.5% midpoint of non-GAAP EPS outlook, and dividend yield based on quarterly rate of $0.527 as of share price on 11/12/24 (2) *Non-GAAP EPS growth of 8.5%, plus ~2.3% dividend yield 4. Refer to https://investors.amdocs.com/ and earnings reports issued on 11/10/2020, 11/2/2021, 11/8/2022, 11/7/2023 and 11/12/2024 for non-GAAP reconciliation in FY2019, FY2020, FY2021, FY2022, FY2023 and FY2024 Information Security Level 2 – Sensitive. © 2024 – Proprietary & Information Security Level 0 – Public. © 2024 – Proprietary & Confidential Information of Amdocs 27 27 Confidential Information of Amdocs

Q1 Fiscal 2025 Outlook Q1 & FY2025 Revenue $1,095 - $1,135 million Outlook $1.20 - $1.29 GAAP EPS (1) Non-GAAP EPS $1.61 - $1.67 Share Count 114 million Positioned to deliver double- Effective Tax Rate Above high-end of annual target range of 15.0% - 17.0% (1) Non-GAAP digit expected total shareholder returns for the fifth Full Year Fiscal 2025 Outlook year running Revenue growth (10.9)% - (7.7%)% As reported Revenue growth 1% - 4.5% (2) (3) Pro forma Constant currency GAAP EPS growth 25.0% - 33.0% (1) Non-GAAP EPS growth 6.5% - 10.5% 1. Non-GAAP. See reconciliation tables in appendix. Free cash flow outlook is before expected restructuring payments Operating Margin 21.1% - 21.7% 2. For comparison purposes, pro forma adjusts fiscal 2024 revenue by (1) Non-GAAP approximately $600 million to reflect the end of certain low margin, non-core business activities which substantially already Effective Tax Rate ceased in the first quarter of fiscal 2025 and are not included in 15.0% - 17.0% (1) the full year fiscal 2025 revenue outlook Non-GAAP 3. Constant currency. Assumes exchange rates in the current period (1) were unchanged from the prior period Free cash flow $710-$730 million Information Security Level 2 – Sensitive. © 2024 – Proprietary & Information Security Level 0 – Public. © 2024 – Proprietary & Confidential Information of Amdocs 30 30 Confidential Information of Amdocs

Reconciliation Tables (a) The amounts under Purchase of property and equipment, net” include immaterial proceeds from sale of property and equipment for the fiscal years ended September 30, 2024 and 2023, respectively. Information Security Level 2 – Sensitive. © 2024 – Proprietary & Information Security Level 0 – Public. © 2024 – Proprietary & Confidential Information of Amdocs 31 31 Confidential Information of Amdocs

Reconciliation Tables Information Security Level 2 – Sensitive. © 2024 – Proprietary & Information Security Level 0 – Public. © 2024 – Proprietary & Confidential Information of Amdocs 32 32 Confidential Information of Amdocs

Thank you!